SynthesisBMC gastroenterology2025

Efficacy and safety of pembrolizumab in advanced gastric and gastroesophageal junction cancer: a systematic review and meta-analysis.

Xiaoying Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.